We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+12.1%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.2B
AUM Growth
+$4.2B
Cap. Flow
+$540M
Cap. Flow %
12.85%
Top 10 Hldgs %
18.08%
Holding
299
New
56
Increased
119
Reduced
60
Closed
32

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$49.4M
2
V icon
Visa
V
+$40.6M
3
ABBV icon
AbbVie
ABBV
+$26.7M
4
AON icon
Aon
AON
+$23.6M
5
C icon
Citigroup
C
+$19.9M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$27.6M
2
CSCO icon
Cisco
CSCO
+$15.5M
3
MCK icon
McKesson
MCK
+$11.4M
4
MU icon
Micron Technology
MU
+$10.7M
5
FLS icon
Flowserve
FLS
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 24.38%
2 Financials 22.67%
3 Healthcare 20.31%
4 Communication Services 9.26%
5 Consumer Discretionary 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRIP icon
76
TripAdvisor
TRIP
$1.67B
$17.9M 0.43%
216,750
+40,150
+23% +$3.28M
WTW icon
77
Willis Towers Watson
WTW
$28.6B
$17.9M 0.43%
151,000
– –
AET
78
DELISTED
Aetna Inc
AET
$17.9M 0.43%
260,866
+54,544
+26% +$3.56M
LLY icon
79
Eli Lilly
LLY
$1.07T
$17.9M 0.42%
350,000
– –
SPNC
80
DELISTED
Spectranetics Corp
SPNC
$17.8M 0.42%
711,950
+14,511
+2% +$311K
MKTG
81
DELISTED
RESPONSYS INC COM STK (CA)
MKTG
$17.7M 0.42%
646,603
+524,767
+431% +$9.57M
PCRX icon
82
Pacira BioSciences
PCRX
$1.05B
$17.6M 0.42%
306,544
-53,875
-15% -$2.83M
MD icon
83
Pediatrix Medical
MD
$2.15B
$17.6M 0.42%
+330,000
New +$17.7M
MRK icon
84
Merck
MRK
$324B
$17.5M 0.42%
366,800
– –
LRCX icon
85
Lam Research
LRCX
$365B
$17.5M 0.42%
3,212,940
+122,500
+4% +$644K
COO icon
86
Cooper Companies
COO
$13.8B
$17.3M 0.41%
560,000
+240,000
+75% +$7.65M
TXI
87
DELISTED
TEXAS INDUSTRIES INC
TXI
$17.3M 0.41%
251,257
+37,702
+18% +$2.22M
ORI icon
88
Old Republic International
ORI
$10.5B
$17.3M 0.41%
1,000,000
– –
WMGI
89
DELISTED
Wright Medical Group Inc
WMGI
$17.2M 0.41%
560,000
+11,949
+2% +$338K
DXCM icon
90
DexCom
DXCM
$28.4B
$17.2M 0.41%
1,940,000
– –
ADBE icon
91
Adobe
ADBE
$94.7B
$17M 0.4%
284,006
-62,950
-18% -$3.48M
ACHC icon
92
Acadia Healthcare
ACHC
$2.97B
$16.8M 0.4%
354,300
+4,300
+1% +$187K
SNDK
93
DELISTED
SANDISK CORP
SNDK
$16.7M 0.4%
237,339
-11,700
-5% -$788K
FLS icon
94
Flowserve
FLS
$9.26B
$16.7M 0.4%
212,047
-146,211
-41% -$10.1M
SPNT icon
95
SiriusPoint
SPNT
$3.01B
$16.7M 0.4%
900,000
– –
EXAM
96
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$16.4M 0.39%
550,000
+29,998
+6% +$833K
BIDU icon
97
Baidu
BIDU
$35.9B
$16.3M 0.39%
91,754
-9,200
-9% -$1.49M
WDC icon
98
Western Digital
WDC
$171B
$16.1M 0.38%
254,072
+146,578
+136% +$8.19M
UHS icon
99
Universal Health Services
UHS
$9.79B
$16.1M 0.38%
+197,659
New +$15.8M
TMH
100
DELISTED
Team Health Holdings Inc
TMH
$16M 0.38%
351,000
+111,000
+46% +$4.94M
2 3
4
5 6

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Polar Capital held 299 positions worth $4.2B, up 112,182% from $3.74M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Polar Capital deployed $540M of net new capital in Q4 2013, opening 56 new positions and adding to 119 existing holdings. Its largest new stake was Pediatrix Medical: 330,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Mastercard, an estimated $27.6M trimmed.

  • Polar Capital's largest Q4 2013 buy was Pediatrix Medical: 330,000 shares worth $17.6M.
  • Polar Capital added most to Apple in Q4 2013, an estimated $49.4M increase.
  • Polar Capital's biggest Q4 2013 reduction was Mastercard, cutting an estimated $27.6M.
  • Polar Capital fully exited Brunswick in Q4 2013, selling an estimated $18.3K.
  • Polar Capital's ten largest holdings make up 18% of its $4.2B portfolio in Q4 2013.
  • Polar Capital opened 56 new positions and closed 32 in Q4 2013.
  • Polar Capital's portfolio value rose 112,182% quarter-over-quarter to $4.2B.

Based on Polar Capital's 13F filing for Q4 2013, filed 11 Feb 2014.